QS — QuantumScape Corporation

Is QS overbought or oversold? Here is the current MarketMoodz read.

Consumer Cyclical · Auto Parts

Strong Oversold As of November 17, 2026

QuantumScape Corporation (QS) currently reads Strong Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Consumer Cyclical name (Auto Parts) last closed at $3.43. The rating moved from Overbought to Strong Oversold on November 13, 2026.

See all oversold Consumer Cyclical stocks →

AI analysis

QuantumScape combines a potentially transformative solid‑state cell architecture and an important OEM partnership with a business profile that is still pre‑commercial and capital intensive. Near term performance will be driven by demonstration milestones, pilot production progress, and financing cadence; failure to show reproducible, scalable cell performance or to secure favorable funding will materially impair valuation. The stock remains highly sensitive to newsflow and retail sentiment, creating high volatility. Over a multi‑quarter horizon the company can deliver substantial upside if technical and manufacturing milestones are met, but near‑term risks from dilution, execution, and competition are elevated.

Key factors

  • Proprietary solid‑state battery technology with potential for higher energy density and faster charging vs. conventional Li‑ion
  • Strategic partnership and investment support from Volkswagen provides validation and a potential early OEM customer pathway
  • Large addressable market as global EV adoption increases, which could drive long‑term revenue if technology and cost targets are met
  • Current financial profile characterized by pre‑revenue operations and significant R&D and scale‑up capital needs
  • Execution path requires successful pilot production, scale‑up to gigafactory economics, and consistent cell performance/aging in real world conditions
  • Retail investor interest and growth‑biased market sentiment can amplify short‑term price moves but also increases volatility

Risks

  • Technical risk: lab success may not translate to reproducible, manufacturable cells at scale with acceptable yields
  • Capital/dilution risk: ongoing negative cash flow and large capital expenditures may force equity dilution or expensive financing
  • Competitive risk: incumbent Li‑ion cost declines and alternative next‑gen chemistries (silicon anodes, improved cell formats) could narrow the advantage
  • Manufacturing risk: scaling to automotive volume requires new processes, suppliers and quality control with steep learning curves
  • Customer concentration/execution risk: dependence on a small set of OEM partners for initial commercialization
  • Macro and market risk: higher rates, tighter financing conditions or an EV demand slowdown would delay revenue and push out commercialization timelines
  • Regulatory/trade and supply‑chain disruptions (including raw‑material availability and pricing) that could increase costs or slow ramp

See today's live rating, score and targets

Members see the live hourly rating for QS — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.